J
John P. Christodouleas
Researcher at University of Pennsylvania
Publications - 130
Citations - 1895
John P. Christodouleas is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Bladder cancer & Cystectomy. The author has an hindex of 22, co-authored 110 publications receiving 1472 citations. Previous affiliations of John P. Christodouleas include Harvard University & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Short-term and long-term health risks of nuclear-power-plant accidents
John P. Christodouleas,Robert Forrest,C. Ainsley,Zelig Tochner,Stephen M. Hahn,Eli Glatstein +5 more
TL;DR: The history of such accidents, along with the short-term and long-term health risks associated with environmental exposure to nuclear fission products, are reviewed.
Journal ArticleDOI
A moving target: Image guidance for stereotactic body radiation therapy for early-stage non-small cell lung cancer
Michael N. Corradetti,Nandita Mitra,Lara P. Bonner Millar,John Byun,Fei Wan,Smith Apisarnthanarax,John P. Christodouleas,N. Anderson,Charles B. Simone,Boon-Keng Kevin Teo,Ramesh Rengan +10 more
TL;DR: Kovoltage x-ray matching to bony anatomy is inadequate for accurate positioning when a conventional 3-5 mm margin is employed prior to lung SBRT, and CBCT image guidance with a 5-mm planning target volume margin is recommended.
Journal ArticleDOI
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours.
Amit Maity,Rosemarie Mick,Alexander C. Huang,Sangeeth M. George,Michael D. Farwell,John N. Lukens,Abigail T. Berman,Tara C. Mitchell,Josh Bauml,Lynn M. Schuchter,Mark H. O'Hara,Lilie L. Lin,Angela DeMichele,John P. Christodouleas,Naomi B. Haas,Dana Patsch,Stephen M. Hahn,Andy J. Minn,E. John Wherry,Robert H. Vonderheide +19 more
TL;DR: HFRT was well tolerated with pembrolizumab, and in some patients with metastatic NSCLC or melanoma, it reinvigorated a systemic response despite previous progression on anti-PD-1 therapy.
Journal ArticleDOI
Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.
Mohamed S. Zaghloul,John P. Christodouleas,Andrew Smith,Ahmed Abdallah,Hany William,Hussein M. Khaled,Wei-Ting Hwang,Brian C. Baumann,Brian C. Baumann +8 more
TL;DR: Adjuvant chemotherapy plus RT was reasonably well tolerated and was associated with significant improvements in LRFS and marginal improvements in disease-free survival vs chemotherapy alone in LABC.
Journal ArticleDOI
Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy
TL;DR: While outcomes are worse for patients unfit for surgery than those otherwise fit for surgery, bladder preservation approaches still offer curative potential.